Pharmafile Logo
Pharmafocus logo
Advanced Search
Roche building

Eleven companies accused in Romanian corruption probe

August 3, 2015
Business Services, Medical Communications, Sales and Marketing China, Daily Telegraph, GSK, Roche, Romania, bribery, corruption

GSK and Roche are among eleven pharma firms being investigated for paying bribes to doctors in Romania to prescribe drugs. …

News
Humira

AbbVie’s Humira receives first European OK for skin condition

August 3, 2015
Sales and Marketing AbbVie, Hidradenitis suppurativa, Humira, adalimumab

The European Commission has approved AbbVie’s Humira as a treatment for moderate-to-severe hidradenitis suppurativa – a chronic condition affecting the …

News
WHO flag

Encouraging first results from trial of Merck’s Ebola vaccine

July 31, 2015
Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination

The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …

News
Doctor online

UK patients ‘self-diagnose rather than visit GP’

July 31, 2015
Medical Communications GP, General Practice, internet

One in five people in the UK admit to self-diagnosing illnesses rather than making a doctor’s appointment. Research published in …

News
ABPI sign

ABPI consulting on Code of Conduct changes

July 31, 2015
Medical Communications, Sales and Marketing ABPI Code, PMCPA, Prescription Medicines Code of Practice Authority, code of conduct

The division of the ABPI that sets rules governing industry behaviour is consulting on changes to reflect new rules on …

News
healthcare tech

Doctors ‘distrust apps developed by pharma’ – survey

July 31, 2015
Medical Communications France, GPs, Germany, Healthcare Technologies, UK, chronic disease, disease management, healthcare tech

A study of GPs in three European countries show GPs feel there is a role for healthcare technologies in disease …

News
depomedlogo

Depomed rejects Horizon’s latest takeover bid

July 30, 2015
Sales and Marketing Depomed, horizon, mergers and acquisitions, takeovers

Depomed has rejected Horizon Pharma’s latest bid, stating the proposal is ‘inadequate’ and ’undervalues’ the company. The Irish pharma company …

News
Aubiago

Sanofi sales boosted by rare disease and multiple sclerosis drugs

July 30, 2015
Manufacturing and Production, Sales and Marketing Genzyme, Oliver Brandicourt, Sanofi, brandicourt, financial results

Sales at pharma giant Sanofi increased by 5% in the second quarter of 2016 to nearly €10 billion, its latest …

News

BMS to trial Opdivo in solid tumours

July 30, 2015
Research and Development BMS, Bristol-Myers Squibb, Kyowa Hakko Kirin, Poteligeo, mogamulizumab, nivolumab, opdivo, solid tumours

Bristol-Myers Squibb will begin early-phase trials of its immuno-oncology treatment Opdivo with other cancer treatments, to see if the combination …

News
Daklinza

NICE restricts access to new hepatitis C treatments

July 29, 2015
Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Exviera, Gilead, NICE, daklinza, harvoni, hepatits C

NICE has recommended three new treatment options for hepatitis C in draft guidance – but has been criticised for excluding …

News
Takeda oncology

Takeda cancer drug gets EMA boost

July 29, 2015
Research and Development, Sales and Marketing Takeda, ixazomib, multiple myeloma

The EMA has granted Takeda an accelerated assessment for its multiple myeloma drug, ixazomib. The Agency’s Committee for Medicinal Products …

News

David Khougazian announced as president of Sanofi Pasteur MSD

July 29, 2015
Business Services, Research and Development, Sales and Marketing MSD, Merck, Sanofi Pasteur

Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …

Appointment
dr_james_shannon

Dr James Shannon joins Immodulon Therapeutics board of directors

July 29, 2015
Research and Development, Sales and Marketing Immodulon

Dr James Shannon has joined Immodulon as a non-executive director with immediate effect. Bringing with him 30 years’ of experience …

Appointment
UCB

Mixed Phase 3 results for Sanofi and UCB

July 29, 2015
Research and Development LixiLan, Sanofi, UCB, clinical trials, epratuzumab, insulin, insulin glargine, phase III

Two drugs that pharma companies are pinning hopes on for future success have had mixed outcomes in key late-stage clinical …

News
Novartis window

Novartis forms Mereo as UK biotech spin-off

July 29, 2015
Research and Development Mereo, Novartis, biotech, rare diseases

Novartis has formed a new UK biotech company by selling three investigational drugs in exchange for shares in the new …

News
AstraZeneca plaque

Cambridge collaboration to boost precision medicine research

July 29, 2015
Research and Development Brabaham Institute, Cambridge, R&D, collaboration

A new consortium has been launched to act as a ‘match-making’ service between pharma companies and R&D researchers to develop …

News
Scales of justice

Judge rules pharma has ‘ethical’ transparency obligation – reaction

July 29, 2015
Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …

News
Gavel

Judge backs HRA in transparency legal case

July 28, 2015
Research and Development EU Clinical Trial Regulation, Richmond Pharmacology, alltrials, clinical trial regulation, clinical trials, health research authority, sense about science, transparency

A judge has ruled that there are likely to be no legal grounds to block the Health Research Authority’s plans …

News
India flag

Lupin buys Gavis to gain first US manufacturing site

July 28, 2015
Manufacturing and Production Gavis, Lupin, manufacturing, production

Indian drug manufacturer Lupin is expanding to the US by purchasing Gavis pharma for $880 million, in a major boost …

News
Regeneron building

Sanofi and Regeneron in immuno-oncology push

July 28, 2015
Manufacturing and Production, Research and Development Cancer, PD-1 inhibitors, Regeneron, Sanofi, collaboration, immuno-oncology, pd-1

Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …

News
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026